Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: Critical role of DNAX accessory molecule-1-poliovirus receptor interaction

Cancer Research

Volumn 64, Issue 24, 2004, Pages 9180-9184

  Castriconi, Roberta ^a,b   Dondero, Alessandra ^a   Corrias, Maria Valeria ^b   Lanino, Edoardo ^b   Pende, Daniela ^c   Moretta, Lorenzo ^a,b   Bottino, Cristina ^b   Moretta, Alessandro ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNAX ACCESSORY MOLECULE 1; MONOCLONAL ANTIBODY; POLIOVIRUS RECEPTOR; PROTEIN; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NEUROBLAST; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CHILD; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; MEMBRANE PROTEINS; NEUROBLASTOMA; RECEPTORS, VIRUS;

EID: 10844246498     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2682     Document Type: Article

References (28)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
2. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a natural killer cell? Nat Immunol 2002;3:6-8.
3. Parham P. Innate immunity: the unsung heroes. Nature (Lond) 2003;423:20.
4. Moretta A, Bottino C, Vitale M, et al. Receptors for HLA-class I molecules in human natural killer cells. Annu Rev Immunol 1996;14:619-48.
5. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999;17:875-904.
6. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002;20:217-51.
7. Lopez-Botet M, Llano M, Navarro F, Bellon T. NK cell recognition of non-classical HLA class I molecules. Semin Immunol 2000;12:109-19.
8. Garrido F, Ruiz-Cabello F, Cabrera T, et al. Implications for immunosurveillance of altered HLA-class I phenotypes in human tumours. Immunol Today 1997;18:89-95.
9. Moretta A, Biassoni R, Bottino C, Mingari MC, Moretta L. Natural cytotoxicity receptors that trigger human NK-mediated cytolysis. Immunol Today 2000;21:228-34.
10. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003;3:781-90.
11. Bottino C, Falco M, Parolini S, et al. NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative diseases. J Exp Med 2001;194:235-46.
12. Marcenaro E, Augugliaro R, Falco M, et al. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity. Eur J Immunol 2003;33:3367-76.
13. Moretta A, Bottino C, Vitale M, et al. Activating receptors and co-receptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19:197-223.
14. Cerwenka A, Lanier LL. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 2001;181:158-69.
15. Brown MH, Boles K, van der Merwe PA, et al. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 1998;188:2083-90.
16. Falco M, Marcenaro E, Romeo E, et al. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. Eur J Immunol 2004;34:1663-72.
17. Bottino C, Castriconi R, Pende D, et al. Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 2003;198:557-67.
18. Reymond N, Imbert AM, Devilard E, et al. DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med 2004;199:1331-41.
19. Costello RJ, Sivori S, Marcenaro E, et al. Defective expression and function of natural killer cell triggering receptors in patients with acute myeloid leukemia. Blood 2002;99:3661-7.
20. Sivori S, Parolini S, Marcenaro E, et al. Involvement of natural cytotoxicity receptors in human natural killer cell mediated lysis of neuroblastoma and glyoblastoma cell lines. J Neuroimmunol 2000;107:220-5.
21. Pende D, Rivera P, Marcenaro S. et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 2002;62:6178-86.
22. Castriconi R, Dondero A, Augugliaro R, et al. Identification of 4Ig-B7-H3 as a novel neuroblastoma-associated molecule that exerts a protective role from natural killer cell-mediated lysis. Proc Natl Acad Sci USA 2004;101:12640-5.
23. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-77.
24. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003;3:203-16.
25. Schwab M, Westermann F, Hero B, Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 2003;4:472-80.
26. Schulz G, Cheresh DA, Varki NM, et al. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res 1984;44:5914-20.
27. Shibuya K, Lanier LL, Phillips JH, et al. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 1999;11:615-23.
28. Fuchs A, Cella M, Giurisato E, Shaw AS, Colonna M. CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J Immunol 2004;172:3994-8.